Advanced search
Publication Cover
OncoTargets and Therapy Volume 13, 2020 - Issue
Submit an article Journal homepage
126
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo

Hezhi Wang1 Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-3194-8086
ORCID Icon,
Xueshuai Ye1 Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China;2 Hebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei, People’s Republic of China
,
Yi Ju3 Department of Medicine, Medical College of Hebei University of Engineering, Handan, Hebei, People’s Republic of China
,
Ziqi Cai2 Hebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei, People’s Republic of China
,
Xiaoxiao Wang4 Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4458-9166
ORCID Icon,
Pingping Du2 Hebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei, People’s Republic of China
,
Mengya Zhang2 Hebei Engineering Technology Research Center for Cell Therapy, Hebei HOFOY Biotech Corporation Ltd., Shijiazhuang, Hebei, People’s Republic of China
,
Yang Li1 Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China
&
Jianhui Cai1 Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China;5 Department of Surgery & Oncology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 3703-3716 | Published online: 04 May 2020

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jingting Min, Chirong Long, Lu Zhang, Jiakang Duan, Honglian Fan, Fei Chu & Zhenghong Li. (2022) c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549. Bioengineered 13:4, pages 9232-9248.
Read now

Articles from other publishers (13)

Shan-Yong Yi, Mei-Zhuo Wei & Ling Zhao. (2024) Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy. Critical Reviews in Oncology/Hematology 196, pages 104313.
Crossref
José Almeida‐Pinto, Matilde R. Lagarto, Pedro Lavrador, João F. Mano & Vítor M. Gaspar. (2023) Cell Surface Engineering Tools for Programming Living Assemblies. Advanced Science 10:34.
Crossref
Caterina D’Accardo, Gaetana Porcelli, Laura Rosa Mangiapane, Chiara Modica, Vincenzo Davide Pantina, Narges Roozafzay, Simone Di Franco, Miriam Gaggianesi, Veronica Veschi, Melania Lo Iacono, Matilde Todaro, Alice Turdo & Giorgio Stassi. (2022) Cancer cell targeting by CAR-T cells: A matter of stemness. Frontiers in Molecular Medicine 2.
Crossref
Hsing-Chuan Tsai, Violena Pietrobon, Maoyu Peng, Suning Wang, Lihong Zhao, Francesco M. Marincola & Qi Cai. (2022) Current strategies employed in the manipulation of gene expression for clinical purposes. Journal of Translational Medicine 20:1.
Crossref
Chunrun Qu, Hao Zhang, Hui Cao, Lanhua Tang, Haoyang Mo, Fangkun Liu, Liyang Zhang, Zhenjie Yi, Lifu Long, Luzhe Yan, Zeyu Wang, Nan Zhang, Peng Luo, Jian Zhang, Zaoqu Liu, Weijie Ye, Zhixiong Liu & Quan Cheng. (2022) Tumor buster - where will the CAR-T cell therapy ‘missile’ go?. Molecular Cancer 21:1.
Crossref
Deepti Singh, Mohammad Afsar Khan & Hifzur R. Siddique. (2022) Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis. Biochemical Pharmacology 198, pages 114955.
Crossref
Malak Hassn Mesrati, Saiful Effendi Syafruddin, M. Aiman Mohtar & Amir Syahir. (2021) CD44: A Multifunctional Mediator of Cancer Progression. Biomolecules 11:12, pages 1850.
Crossref
Yuanyuan Zheng, Yan Li, Jiao Feng, Jingjing Li, Jie Ji, Liwei Wu, Qiang Yu, Weiqi Dai, Jianye Wu, Yingqun Zhou & Chuanyong Guo. (2021) Cellular based immunotherapy for primary liver cancer. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Jian Xue, Hongbo Ni, Fan Wang, Ke Xu & Meng Niu. (2021) Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy. Journal of Interventional Medicine 4:3, pages 105-113.
Crossref
Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani & Fatemeh Rahbarizadeh. (2021) Novel antigens of CAR T cell therapy: New roads; old destination. Translational Oncology 14:7, pages 101079.
Crossref
Cláudia P. A. Alves, Duarte Miguel F. Prazeres & Gabriel A. Monteiro. (2021) Minicircle Biopharmaceuticals–An Overview of Purification Strategies. Frontiers in Chemical Engineering 2.
Crossref
Simone Hager, Frederic Julien Fittler, Ernst Wagner & Matthias Bros. (2020) Nucleic Acid-Based Approaches for Tumor Therapy. Cells 9:9, pages 2061.
Crossref
Xinran Li. (2020) Cancer Stem Cell as Target of CAR-T Cell Therapy. E3S Web of Conferences 218, pages 03043.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.